Titlebook: Nanoengineering Materials for Biomedical Uses; Emilio I. Alarcon,Manuel Ahumada Book 2019 Springer Nature Switzerland AG 2019 Regenerative

從未沮喪

書目名稱Nanoengineering Materials for Biomedical Uses影響因子(影響力)




書目名稱Nanoengineering Materials for Biomedical Uses影響因子(影響力)學(xué)科排名




書目名稱Nanoengineering Materials for Biomedical Uses網(wǎng)絡(luò)公開度




書目名稱Nanoengineering Materials for Biomedical Uses網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nanoengineering Materials for Biomedical Uses被引頻次




書目名稱Nanoengineering Materials for Biomedical Uses被引頻次學(xué)科排名




書目名稱Nanoengineering Materials for Biomedical Uses年度引用




書目名稱Nanoengineering Materials for Biomedical Uses年度引用學(xué)科排名




書目名稱Nanoengineering Materials for Biomedical Uses讀者反饋




書目名稱Nanoengineering Materials for Biomedical Uses讀者反饋學(xué)科排名

短程旅游

http://image.papertrans.cn/n/image/660735.jpg

Lasting

NIP

978-3-030-31263-3Springer Nature Switzerland AG 2019

GUMP

Emilio I. Alarcon,Manuel AhumadaExplains the latest developments in applying nanomaterials to medical treatment.Includes applications in cardiac surgery, bone, eye, nerve, and skin diseases as well as in biomedical devices.Is the on

支架

Advanced Surface Characterization Techniques in Nano- and Biomaterials,patients, will ultimately be invaded by endogenous cells, which emphasizes the relevance of surface composition as a critical factor in determining the regenerative potency of a given material. In this chapter, we present a brief revision on fundamental concepts and an up-to-date overview for surface characterization of nano-engineered structures.

豐滿中國

Nanomaterials for Its Use in Biomedicine: An Overview,ve halted the progression for developing novel structures for tissue repair. In the present chapter, we revise fundamental concepts to be considered when designing technologies that will have to undergo scrutiny by regulatory agencies?prior to being used in humans.

仲裁者

Regulatory Normative of Nanomaterials for Their Use in Biomedicine,ation. In this chapter, we describe the regulatory landscape with regards to nanomedicines in various countries. We first start with the world’s nanotechnological leaders in North America, the European Union, and Asian and then discuss the notable strides taken by emerging countries where nanomedicines have caught the public eye.

JOG

期滿